The 2022 Annual Conference of ISHR-NAS: Advances in Cardiovascular Medicine Through Diversity, Equity, and Inclusion; Focusing on Education and Technological Innovation

该提案要求NHLBI支持第41届国际心脏学会年会 研究（ISHR）-北美部分（NAS）在2022年。作为ISHR-NAS的现任主席（2018-2021）， 我非常荣誉能够担任R13应用程序的PI，并与NAS上的同事一起工作 领导团队，Lorri Kirshenbaum博士（会议主席），Maria Kontartik博士和Jennifer货车Eyk博士 （会议联合主席），大卫勒费尔博士，下一任NAS总裁（2022-2024），和凯利布罗德斯基女士（执行 我们将继续在ISHR-NAS会议上取得成功。我们的ISHR-NAS 2021会议在丹佛 是一个非常成功的;我们有信心的基础上，在过去四年的NAS成员的稳步增长 预计2022年的会议将吸引约250-300名与会者。自2021年春季以来，我们一直在 共同策划一个在心血管生物学和医学领域具有广泛影响的一流会议。 总之，会议组织者在执行国家和国际 我们的专业知识涵盖广泛的学科。我们完全预计， 优秀的团队将使2022 ISHR-NAS会议取得又一个令人瞩目的成功。 我们的目标将得到这些目标的支持：目标1是提升和丰富年轻研究人员的职业生涯， 以方便他们的发射。目的2是阐明最近的科学发展，在独特的心血管疾病 通过基础和临床科学与工业参与的结合，目标3：呈现出... 最先进的心血管科学通过互动领域，包括小组讨论，其中坦率，直接 强调对心血管社区面临的挑战和重要问题的辩论。许多 会议的组成部分深深植根于促进心血管疾病的多样性，公平性和包容性。 药 这次会议包含一个充满活力的科学计划，其特点是为ECIs和MCI举办为期一天的特别会议， 科学研讨会，2个青年研究者竞赛，5个讲习班，3个专题讲座，和几个社区- 建立网络活动。初步计划共包括104名受邀演讲者和小组成员 （约80%确认，51%是女性），代表着一流的学术课程和工业研究实体 分布在美国24个州的35个城市和加拿大的6个城市。通过实施机制， 最大限度地提高女性和URM发言者的参与，本次会议提供了宝贵的机会，以支持 ISHR-NAS关于多样性、公平和包容的使命。初步方案包括大于 50%女性此外，我们还专门为代表性不足的少数群体分配了30个旅行奖 （URMs），以进一步促进平等和平等机会。会议的每一个方面都将 支持NHLBI的使命，即促进心脏病的预防和治疗， 个人的健康。

This proposal requests NHLBI’s support for the 41st Annual Conference of the International Society for Heart Research (ISHR)—North American Section (NAS) in 2022. As the current President of ISHR-NAS (2018-2021), it is my great honor to serve as the PI of this R13 application and together with my colleagues on the NAS leadership team, Dr. Lorri Kirshenbaum (conference chair), Dr. Maria Kontaridis and Dr. Jennifer Van Eyk (conference co-chairs), Dr. David Lefer, the next NAS President (2022-2024), and Ms. Kelley Brodsky (Executive Administrator), we will continue the success in ISHR-NAS meetings. Our ISHR-NAS 2021 meeting in Denver was an excellent success; we are confident based on the steady growth of NAS membership over the past four years that this 2022 meeting will attract approximately 250-300 attendees. Since spring of 2021, we have been working together to plan a first-class conference with broad impact in cardiovascular biology and medicine. Together, the meeting organizers have extensive experience in implementing national and international conferences, and our scientific expertise covers a broad range of disciplines. We fully anticipate that this outstanding team will make the 2022 ISHR-NAS conference another riveting success. Our goals will be supported by these aims: Aim 1 is to elevate and enrich the careers of young investigators in order to facilitate their launch. Aim 2 is to illuminate recent scientific developments in unique cardiovascular domains via the marriage of basic and clinical science with industrial participation. Aim 3 is to present state-of- the-art cardiovascular science through interactive domains, including panel discussions where candid, direct debates on challenges and important issues faced by the cardiovascular community are emphasized. Many components of the meeting are deeply rooted in promoting Diversity, Equity, and Inclusion in cardiovascular medicine. This meeting contains a vibrant scientific program that features special 1-day sessions for ECIs and MCIs, 21 scientific symposia, 2 young investigator competitions, 5 workshops, 3 featured lectures, and several community- building networking events. The preliminary program contains a total of 104 invited speakers and panelists (~80% confirmed, 51% are female), representing premier academic programs and industrial research entities located from 35 cities across 24 States in the US and 6 cities in Canada. By implementing mechanisms to maximize the participation of female and URM speakers, this meeting offers valuable opportunities to support the ISHR-NAS mission on Diversity, Equity, and Inclusion. The preliminary program consists of greater than 50% female. Moreover, we have allocated 30 travel awards specifically for underrepresented minority groups (URMs) in order to further promote equality and equal opportunities. Every aspect of the meeting will go to support the NHLBI mission of promoting the prevention and treatment of heart diseases and enhancing the health of individuals.